Completion Dissection or Observation for Sentinel-Node Metastasis in Melanoma
Mark B. Faries, John F. Thompson, Alistair J. Cochran et al. · New England Journal of Medicine · 2017
BACKGROUND: Sentinel-lymph-node biopsy is associated with increased melanoma-specific survival (i.e., survival until death from melanoma) among patients with node-positive intermediate-thickness melanomas (1.2 to 3.5 mm). The value of completion lymph-node dissection for patients with sentinel-node metastases is not clear. METHODS: In an international trial, we randomly assigned patients with sentinel-node metastases detected by means of standard pathological assessment or a multimarker molecular assay to immediate completion lymph-node dissection (dissection group) or nodal observation with ultrasonography (observation group). The primary end point was melanoma-specific survival. Secondary end points included disease-free survival and the cumulative rate of nonsentinel-node metastasis. RESULTS: Immediate completion lymph-node dissection was not associated with increased melanoma-specific survival among 1934 patients with data that could be evaluated in an intention-to-treat analysis or among 1755 patients in the per-protocol analysis. In the per-protocol analysis, the mean (±SE) 3-year rate of melanoma-specific survival was similar in the dissection group and the observation group (86±1.3% and 86±1.2%, respectively; P=0.42 by the log-rank test) at a median follow-up of 43 months. The rate of disease-free survival was slightly higher in the dissection group than in the observation group (68±1.7% and 63±1.7%, respectively; P=0.05 by the log-rank test) at 3 years, based on an increased rate of disease control in the regional nodes at 3 years (92±1.0% vs. 77±1.5%; P<0.001 by the log-rank test); these results must be interpreted with caution. Nonsentinel-node metastases, identified in 11.5% of the patients in the dissection group, were a strong, independent prognostic factor for recurrence (hazard ratio, 1.78; P=0.005). Lymphedema was observed in 24.1% of the patients in the dissection group and in 6.3% of those in the observation group. CONCLUSIONS: Immediate completion lymph-node dissection increased the rate of regional disease control and provided prognostic information but did not increase melanoma-specific survival among patients with melanoma and sentinel-node metastases. (Funded by the National Cancer Institute and others; MSLT-II ClinicalTrials.gov number, NCT00297895 .).
Cited by 1,414 works. doi:10.1056/nejmoa1613210 Open-access PDF
Authors
- Mark B. Faries
- John F. Thompson
- Alistair J. Cochran
- Robert H.I. Andtbacka
- Nicola Mozzillo
- Jonathan S. Zager
- Tiina Jahkola
- Tawnya Lynn Bowles
- Alessandro Testori
- Peter D. Beitsch
- Harald J. Hoekstra
- Marc D. Moncrieff
- Christian Ingvar
- Michel W.J.M. Wouters
- Michael S. Sabel
- Edward Allen Levine
- Doreen Marie Agnese
- Michael A. Henderson
- Reinhard Dummer
- Carlo Riccardo Rossi
References
- Sentinel-Node Biopsy or Nodal Observation in Melanoma
- Final Trial Report of Sentinel-Node Biopsy versus Nodal Observation in Melanoma
- Sentinel Node Biopsy for Early-Stage Melanoma
- Diagnosis and treatment of melanoma. European consensus-based interdisciplinary guideline – Update 2016
- Complete lymph node dissection versus no dissection in patients with sentinel lymph node biopsy positive melanoma (DeCOG-SLT): a multicentre, randomised, phase 3 trial
- Sentinel Lymph Node Biopsy for Melanoma: American Society of Clinical Oncology and Society of Surgical Oncology Joint Clinical Practice Guideline
- Prediction of metastatic melanoma in nonsentinel nodes and clinical outcome based on the primary melanoma and the sentinel node
- The Impact on Morbidity and Length of Stay of Early Versus Delayed Complete Lymphadenectomy in Melanoma: Results of the Multicenter Selective Lymphadenectomy Trial (I)
- Diagnosis and treatment of melanoma. European consensus-based interdisciplinary guideline – Update 2012
- Melanoma Patients with Positive Sentinel Nodes Who Did Not Undergo Completion Lymphadenectomy: A Multi-Institutional Study